PRPO
NASDAQ
$23.40
Precipio Inc (PRPO)
Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.
Sector:
Healthcare
Industry:
Diagnostics & Research
Target: $19 (-18.80%)
Market Cap
$45M
Revenue 5Y CAGR
+26.68%
Free Cash Flow Yield
1.23%
Beta (5Y)
0.76
Price Chart
Valuation
Market Cap$45M
Forward P/E15.43
P/S1.60
P/B2.97
Profitability
Total Revenue (TTM)$26M
Gross Profit (TTM)$11M
EBITDA-$569K
Profit Margin-20.7%
Operating Margin-20.5%
EPS-$0.51
Financial Health
Debt-to-Equity0.5%
Free Cash Flow Yield1.23%
Growth & Risk
EPS 5Y CAGR-45.62%
Revenue 5Y CAGR+26.68%
Beta (5Y)0.76
Sharpe Ratio1.01